Data visualisation application speeds lead discovery

Published: 31-Aug-2010
Manufacturing Research & Development

Merck Millipore has new software for visualising GPCR and kinase activity

The Life Science division of Merck KGaA, Merck Millipore has introduced a software application for visualising GPCR (G-protein coupled receptors), as well as kinase activity.

The new Data Analysis and Report Tool (DART) creates an interactive map of target profiling assay results and enables drug researchers to make faster, more informed decisions.

‘Lead profiling often requires sifting through hundreds or even thousands of data points to pinpoint targets for further optimization studies,’ said Paul Wilhite, senior manager of eBusiness at Merck Millipore. ‘This new online tool provides a unique, information-rich interface so scientists can rapidly narrow their research and effectively collaborate with colleagues.’

The application projects each compound's activity profile onto a map depicting clusters of target protein families. This map provides scientists with immediate graphical insight into cross-target interactions to help drive structure-activity relationship (SAR) studies. The application is fully customisable. Data limits, sizing, colours, and target subclasses can be adjusted in seconds, thereby turning numerical data into a graphical display that can highlight biologically significant conclusions. Additionally, selected target information is dynamically populated and includes the gene symbol and aliases; links to bioinformatics content and recent publications; as well as links to appropriate Merck Millipore products.

Users of Merck Millipore's KinaseProfiler and GPCRProfiler screening services can upload their data directly into the DART tool or enter other datasets manually to take advantage of the software's analytical power and presentation-quality images.

See more

You may also like

Manufacturing

Key drivers behind the rise of microsphere drug delivery systems

Read more
Microspheres shift drug delivery from broad distribution to precise targeting. These systems improve therapeutic consistency, lower systemic exposure, and adapt to complex treatment regimens. Their growth reflects progress in polymer science, pharmacokinetics, and the push for more individualised care in clinical settings. Let’s explore some of the key drivers behind the rise of microsphere drug delivery systems and look ahead to predict future growth trends

Trending Articles

  1. IMA Life-Sharp Sterile Manufacturing partnership strengthened with aseptic technology facility Sharp's expanded facility in Massachusetts will include the installation of a fully automated IMA Life isolated filling line for Ready-To-Use (RTU) vials, addressing demand for US-based aseptic fill-finish services
  2. FDA and EMA issue guiding principles for AI in drug development The set of ten principles gives broad guidance on AI use in evidence generation and monitoring across all phases of a medicine, from early research and clinical trials to manufacturing and safety monitoring
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Miniaturisation in medtech: mechanical factors that influence product success Medical devices are becoming smaller, lighter and more portable. From handheld diagnostic tools to wearable infusion pumps and compact surgical instruments, reduced size is now a defining feature of many new medtech products
  4. Enara Bio expands Boehringer Ingelheim partnership as DARKFOX programme moves toward the clinic Enara Bio has entered 2026 with renewed momentum after Boehringer Ingelheim licensed additional Dark Antigen targets under their oncology collaboration. The company is also continuing to expand its EDAPT discovery platform
  5. Thermo Fisher unveils HepatoExpress kit for liver cell gene expression analysis The new Invitrogen TaqMan Cells-to-CT HepatoExpress Kit eliminates the need for traditional RNA purification, streamlining workflows and reducing time to results and offers less plastic waste compared to traditional RNA purification methods

Upcoming event

Pharmapack

21–22 January 2026 | Exhibition | Paris, France See all

You may also like

Manufacturing

Key drivers behind the rise of microsphere drug delivery systems

Microspheres shift drug delivery from broad distribution to precise targeting. These systems improve therapeutic consistency, lower systemic exposure, and adapt to complex treatment regimens. Their growth reflects progress in polymer science, pharmacokinetics, and the push for more individualised care in clinical settings. Let’s explore some of the key drivers behind the rise of microsphere drug delivery systems and look ahead to predict future growth trends
Manufacturing

Inside the shift toward greener, faster, Smarter drug manufacturing

Dave Henderson, Ph.D, MBA, Head of R&D Labs at Asymchem explores the pharmaceutical manufacturing landscape and the challenges CDMOs must address to remain competitive in this shifting market
Manufacturing

Onyx Scientific boosts solid form and particle engineering capabilities

Marking its 25th anniversary, Onyx Scientific has invested in new crystallisation, particle imaging and processing technologies to accelerate development of complex molecules across early and late stages
Manufacturing

Cellistic launches new iPSC-based GMP platforms to boost cell therapy development

Echo-T, Echo-Cardio, and Echo-Endothelial enable scalable immuno-oncology and regenerative therapies
Research & Development

FDA and EMA issue guiding principles for AI in drug development

The set of ten principles gives broad guidance on AI use in evidence generation and monitoring across all phases of a medicine, from early research and clinical trials to manufacturing and safety monitoring
Manufacturing

Labinox by Labtex - Precise, bespoke stainless steel fabrications

Manufactured in 316-grade stainless steel and built according to customers’ designs and dimensions, our expertise ranges from simple fabrications and machining to high specification projects
Manufacturing

Hongene Biotech receives Gates Foundation grant to expand global access to mRNA vaccine raw materials

The company will use the grant to develop high-quality, affordable and patent-free cap analogues for use in mRNA vaccine production
Subscribe now